FinVector’s Breakthrough in Suspension Cell Cultures: The Future of AAV Production How Can Viral Vector Manufacturing Processes Be Optimized for Higher Yields?
Optimizing viral vector manufacturing is a critical step in advancing gene therapies and vaccine production. Several innovations have emerged to address the inefficiencies traditionally associated with the process.
For instance, Catalent Inc. and Avid Bioservices have invested heavily in single-use...
0 Shares
213 Views
0 Reviews